Prostate cancer: open trials in Hong Kong

28 open trials have a site in Hong Kong. Registry data; only the trial team decides who can take part.

NCT06262633
A Multi-centre Trial on Targeted Microwave Ablation (TMA) for Localized Prostate Cancer: The VIOLETTA Trial
Trial Treatment · Chinese University of Hong Kong
Peter Ka-Fung CHIU, Shatin
Registry updated 2026-11-06
NCT07650448
WATER IV PCa (AS Sub-study)
Trial Treatment · PROCEPT BioRobotics
Chinese University of Hong Kong, Shatin
Registry updated 2026-11-06
NCT06136624
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Queen Mary Hospital (Site 0727), Hong Kong · Prince of Wales Hospital (Site 0730), Shatin
Registry updated 2026-11-05
NCT05443412
Artificial Intelligence (AI)-Assisted Risk-based Prostate Cancer Detection
Research · Chinese University of Hong Kong
Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong
Registry updated 2026-11-03
NCT06360523
To Evaluate an MRI-based Optimized Prostate Cancer Diagnostic Pathway Powered by Artificial Intelligence
Trial Treatment · Chinese University of Hong Kong
Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong
Registry updated 2026-11-03
NCT06740071
The Application of Somatosensory Interactive Pelvic Floor Muscle Training for Stress Urinary Incontinence in Men Underwent Radical Prostatectomy
Trial Treatment · The University of Hong Kong
Queen Mary Hospital, Hong Kong
Registry updated 2026-11-02
NCT06925737
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Queen Mary Hospital (Site 0415), Hong Kong · Tuen Mun Hospital (Site 0416), New Territories
Registry updated 2026-10-30
NCT06163924
The Effect of Multidisciplinary Care Approach on CV Risk Modification in CaP Patients Receiving ADT
Research · Chinese University of Hong Kong
The Chinese University of Hong Kong, Hong Kong
Registry updated 2026-10-28
NCT03893929
The Investigation of New Biological Markers for Prostate Cancer Diagnosis and Management in Chinese Population
Research · Chinese University of Hong Kong
Prince of Wales Hospital, Shatin
Registry updated 2026-10-27
NCT03914391
To Identify Potential New Urine Markers for the Screening of Prostate Cancer
Research · Chinese University of Hong Kong
Prince of Wales Hospital, Shatin
Registry updated 2026-10-27
NCT06303622
Comparing MRI-Ultrasound Fusion and Cognitive-guided Biopsy for the Detection of csPCa: the PROFUSION Trial
Trial Treatment · Chinese University of Hong Kong
Prince of Wales Hospital, Hong Kong
Registry updated 2026-10-27
NCT06886321
Prostate Irreversible Electroporation Study
Trial Treatment · Chinese University of Hong Kong
Prince of Wales Hospital / The Chinese University of Hong Kong, Hong Kong
Registry updated 2026-10-27
NCT07386496
The Role of 18F-PSMA PET in Prostate Cancer Diagnosis in Equivocal MRI
Trial Treatment · Chinese University of Hong Kong
Prince of Wales Hospital, Hong Kong
Registry updated 2026-10-27
NCT05946213
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Trial Treatment · Phase 3 · NRG Oncology
Pamela Youde Nethersole Eastern Hospital, Chai Wan
Registry updated 2026-10-23
NCT03344835
Hong Kong Prostate Cancer Study Group Database
Research · Chinese University of Hong Kong
Prince of Wales Hospital, Shatin
Registry updated 2026-10-22
NCT07057375
The Effect of Pulsed Electromagnetic Field Therapy on Muscle Mass and Muscle Strength in Prostate Cancer Patients Treated With Androgen Deprivation Therapy
Trial Treatment · Chinese University of Hong Kong
Prince of Wales Hospital, Shatin
Registry updated 2026-10-22
NCT07760857
Investigation of an Intelligent Centre-adaptive Multi-modal Fusion Framework (Cad- MMFF) to Overcome Unnecessary Prostate Biopsies and Optimize MRI Utilization
Research · Chinese University of Hong Kong
Prince of Wales Hospital, Hong Kong · North District Hospital, Sheung Shui
Registry updated 2026-10-22
NCT06136650
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Hong Kong Integrated Oncology Centre (Site 0603), Central · Queen Mary Hospital (Site 0602), Hong Kong
Registry updated 2026-10-20
NCT06855277
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Hong Kong
Registry updated 2026-10-15
NCT07711002
Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
Trial Treatment · Phase 3 · AstraZeneca
Hong Kong
Registry updated 2026-10-15
NCT07568236
A Trial on Fezolinetant for Vasomotor Symptoms in Men Receiving Androgen Deprivation Therapy (ADT)
Trial Treatment · Phase 2 · Chinese University of Hong Kong
Prince of Wales Hospital, Shatin
Registry updated 2026-10-07
NCT06784193
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 1 · Olema Pharmaceuticals, Inc.
Queen Mary Hospital, Hong Kong
Registry updated 2026-10-05
NCT07190300
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Trial Treatment · Phase 1/2 · Novartis Pharmaceuticals
Hong Kong
Registry updated 2026-09-29
NCT06780670
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Trial Treatment · Phase 2/3 · Novartis Pharmaceuticals
Hong Kong
Registry updated 2026-09-22
NCT07792590
Registry for Prostate Cancer Focal Therapy
Research · The University of Hong Kong
Queen Mary Hospital, Hong Kong
Registry updated 2026-08-28

All Prostate cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error